Board

Editorial Board Biographies

Editor in Chief: Brian M Frier, MD FRCPE (Edinburgh, UK)
Brian Frier is Consultant Physician in general (internal) medicine and diabetes at the Royal Infirmary of Edinburgh and is Honorary Professor of Diabetes in the University of Edinburgh. Professor Frier’s principal research interest is the pathophysiology of hypoglycemia in humans with particular relevance to diabetes. He has published extensively in this field and has co-edited two multi-author international textbooks on hypoglycemia and diabetes: Hypoglycaemia and Diabetes: Clinical and Physiological Aspects, and Hypoglycaemia in Clinical Diabetes (now in Second edition). His other research interests include: insulin therapy, the complications of diabetes and driving and diabetes. He is currently the Chairman of the UK National Advisory Panel on Driving and Diabetes.

Simon Heller, BA MB BChir DM FRCP (Sheffield, UK)
Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Foundation Trust. He received his clinical diabetes training at Queen’s Medical Centre, Nottingham and his research training at the University of Nottingham and Washington University, St Louis, USA. His current research interests include the physiological responses to hypoglycemia and hypoglycemia unawareness, pathophysiological mechanisms of sudden death in type 1 diabetes and developing interventions to encourage more effective diabetes self-management. He was Editor in Chief of Diabetic Medicine between 2000 and 2004. He is currently a member of Diabetes UK Research Committee, JDRF Scientific Review Board and the MRC College of Experts.

Rory J McCrimmon, MBChB MD FRCP (Dundee, UK)
Rory McCrimmon holds the post of Clinical Senior Lecturer at the University of Dundee. His primary research interest is the exploration of the underlying mechanisms by which the brain, and in particular specific hypothalamic nuclei, sense falling blood glucose and trigger a neuroendocrine stress response in iatrogenic hypoglycemia in individuals with diabetes. His research group is also interested in studying those factors that modulate the neuroendocrine stress response to try and understand why this system is impaired in diabetes. His ongoing projects use in vivo microinjection, microdialysis, and gene therapy approaches in animal models (rat and transgenic mice) as well as neuroimaging studies in human subjects.

Christopher M Ryan, PhD (Pittsburgh, USA)
Christopher Ryan holds the posts of Professor of Psychiatry at the University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, Professor of Health and Community Systems at the University of Pittsburgh School of Nursing and Professor of Psychology at the University of Pittsburgh. He is interested in the effects of various medical disorders and medical therapies on cognitive functioning in both children and adults. He is currently involved in the first study of diabetic patients to delineate changes in cognitive functioning from late childhood into middle-adulthood. This study is also the first to link functional changes to diabetes-related biomedical variables.

Anthony L McCall, MD PhD FACP (Virginia, USA)

Some contributors of commissioned content to Diabetic Hypoglycemia may receive a nominal honorarium from the publisher (ESP Bioscience).